Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X
Go back to Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X| (AMEX: MBCOF) | Delayed: 0.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.11 | 52 Week High | $ | |||
| Open | $0.11 | 52 Week Low | $ | |||
| Day High | $0.11 | P/E | N/A | |||
| Day Low | $0.11 | EPS | $ | |||
| Volume | 10 | |||||
| Marvell Technology Group Ltd (NASDAQ: MRVL) | Delayed: 223.55 +14.72 (7.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $208.83 | 52 Week High | $13.61 | |||
| Open | $211.66 | 52 Week Low | $7.40 | |||
| Day High | $223.67 | P/E | 349.30 | |||
| Day Low | $210.87 | EPS | $0.64 | |||
| Volume | 21,197,358 | |||||
